IKZF3
IKZF3, also known as Aiolos or ZNFN1A3, is a lymphocyte-restricted C2H2-type zinc-finger transcription factor of the Ikaros family. It regulates B-cell differentiation, proliferation and maturation, and contributes to apoptosis control in T-cells. Browse Assay Genie's current range of IKZF3 research reagents below, or read on for the biology behind the target.
IKZF3 is a transcription factor that plays an important role in the regulation of lymphocyte differentiation. It has an essential role in B-cell differentiation, proliferation and maturation to an effector state. It is also involved in regulating BCL2 expression and in controlling apoptosis in T-cells in an IL-2-dependent manner. Like other Ikaros family proteins, it can participate in chromatin remodelling.
The IKZF3 gene encodes a member of the Ikaros family of zinc-finger proteins, classed by HGNC within the C2H2-type zinc fingers. Three members of this family, Ikaros, Aiolos and Helios, are haematopoietic-specific transcription factors involved in regulating lymphocyte development. The protein is found in the nucleus and the cytoplasm. Regulation of gene expression in B lymphocytes by Aiolos is complex: it appears to require the sequential formation of Ikaros homodimers, Ikaros/Aiolos heterodimers and Aiolos homodimers. Several alternative transcripts encoding different isoforms have been described, as well as some non-protein coding variants.
The gene was previously named zinc finger protein, subfamily 1A, 3 (Aiolos), hence the symbol ZNFN1A3, and the protein is commonly called Aiolos. The mouse ortholog is Ikzf3. Researchers studying the IKZF3 gene or Aiolos protein often examine it alongside its relatives Ikaros (IKZF1) and other family members, given the cooperative dimerisation that shapes its activity in B lymphocytes.
IKZF3 is essential for B-cell differentiation, proliferation and maturation to an effector state, making it a key factor in B lymphocyte biology.
As a haematopoietic-specific Ikaros family member, IKZF3 helps regulate lymphocyte development and differentiation.
IKZF3 is involved in regulating BCL2 expression and controlling T-cell apoptosis in an IL-2-dependent manner.
Aiolos participates in chromatin remodelling, and its activity depends on Ikaros and Aiolos homodimer and heterodimer formation.
IKZF3 is a transcription factor that regulates lymphocyte differentiation. It is essential for B-cell differentiation, proliferation and maturation to an effector state, and it helps regulate BCL2 expression and apoptosis in T-cells in an IL-2-dependent manner.
Yes. Aiolos is the common name of the IKZF3 protein, and ZNFN1A3 is a previous gene symbol. UniProt lists it as zinc finger protein Aiolos. Several alternative transcripts encoding different isoforms have been described, along with some non-protein coding variants.
IKZF3 belongs to the Ikaros family of C2H2-type zinc-finger proteins, alongside Ikaros and Helios, all haematopoietic-specific regulators of lymphocyte development. In B lymphocytes, Aiolos activity appears to require Ikaros homodimers, Ikaros/Aiolos heterodimers and then Aiolos homodimers. The mouse ortholog is Ikzf3.
Other Ikaros family zinc-finger transcription factors involved in lymphocyte development.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q9UKT9; product specifications from Assay Genie datasheets.